Interleukin & HIV/AIDS: Research
The Basics
- HIV/AIDS Study -- Link to Rapid Advancement of HIV Virus Found in Semen: NIH (February 15, 2013)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
 Immune System Protein in Semen Boosts HIV Spread in Female Genital Tissue (February 8, 2013)
NIH study suggests virus uses protein to spread.
From U.S. National Institutes of Health
On TheBodyPRO.com
- Interleukin-2 (May 28, 2012)
To read PDF, click here.
From AIDS InfoNet
- IL-7 Making its Debut (February 2010)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
- Research Shows Treating HIV/AIDS With Interleukin-2 Is Ineffective (October 23, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- An Overview of Aldesleukin (IL-2, Proleukin) (June 7, 2009)
From AIDSinfo
- Interleukin-2 (IL-2, Proleukin) (March 2007)
To read PDF, click here.
From Project Inform
- IL-2 (August 15, 2006)
From AIDS Treatment Data Network
- The Development Pipeline for Cytokines, Immunomodulators and Gene Therapy (September 29, 2005)
In TAGline, from Treatment Action Group
- Interleukin-2: SILCAAT Study to Continue (October 2003)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
On TheBodyPRO.com
VIEW ALL ARTICLES
Trial Results
- IL-2 Confers No Long-Term Benefits (Winter/Spring 2009)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Intriguing IL2 Study Results May Offer Unique Solution (August 6, 2008)
From Project Inform
- Interleukin-2 Ineffective in Maintaining Baseline CD4+ Cell Count During Treatment Interruption (February 6, 2008)
From TheBodyPRO.com
- TILT: A Look at the Role of Interleukin-2 in Treatment Interruption Leans Toward the Negative (February 28, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Interleukin-2 Expands Select CD4+ T-Cell Populations, but Has No Effect on HIV-Specific Immune Responses (February 26, 2007)
In Exclusive Coverage of the 14th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- Scientists Explore Possible New Way to Fight AIDS (February 8, 2007)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Comparing a Treatment Interruption With or Without Interleukin-2 in Delaying a Falling CD4+ Cell Count (February 25, 2005)
In The 12th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- HIV Patients Get Long-Term Boost With Short, Intermittent Drug Regimen (April 26, 2004)
From U.S. National Institute of Allergy and Infectious Diseases
- Immunological and Virological Efficacy of ALVAC-VIH 1433 and HIV Lipopeptides (Lipo-6T) Combined With SC IL-2 in Chronically HIV-Infected Patients -- Results of the ANRS 093 Randomized Study (February 12, 2003)
In The 10th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
- IL-2 & CD4 T Cells: Number & Function Disconnect? (January/February 2003)
In TAGline, from Treatment Action Group
VIEW ALL ARTICLES
Interviews with Doctors
|
Advertisement
|
Email
Glossary
